While the study focused on development of antibody therapeutics against existing and emerging viral threats, the implications of the research are much broader.

The Department of PM&I continues to be one of the leading and most innovative of its kind in the nation.

To launch a connection search, someone with a specific gene variant signs up to meet others who share that variant, beginning a process of discovering new connections with unknown relatives and encouraging family members to get tested.

Byndloss, who joined the Vanderbilt faculty in 2018, studies the links between the gut microbiota (the microorganisms that reside in the intestines), host metabolism and disease.

Researchers will scan the landscape of plasmablasts, the first antibody-producing, B-type immune cells that respond to MMR infection.

The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume.

Each year the JCC Fund awards three years of salary support to 25-30 of the “best and brightest” postdoctoral fellows.